Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Pharmaceutical Sciences
|
June 5, 2007
Near infrared spectroscopy of magnesium stearate hydrates and multivariate calibration of pseudopolymorph composition
John F Kauffman, Venkat Tumuluri, Changning Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 6, 2005
IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients
Jeffrey H Stack, Kevin Beaumont, Paul D Larsen, et al.
Epilepsia
|
August 5, 2006
Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy
Teresa Ravizza, Sian-Marie Lucas, Silvia Balosso, et al.
Antiviral Therapy
|
December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients
Keyur Patel, Seng G Lim, Chow W Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2007
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18
Woods Wannamaker, Robert Davies, Mark Namchuk, et al.
Plos Computational Biology
|
April 27, 2010
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants
Bambang S Adiwijaya, Eva Herrmann, Brian Hare, et al.
ACS Pharmacology & Translational Science
|
October 18, 2024
Chimeras Derived from a P2Y<sub>14</sub> Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation
Zhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Journal of Medicinal Chemistry
|
March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres
Young-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
Journal of Medicinal Chemistry
|
February 3, 2022
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y<sub>14</sub>R Antagonist
Zhiwei Wen, Veronica Salmaso, Young-Hwan Jung, et al.
Journal of Medicinal Chemistry
|
June 29, 2023
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y<sub>14</sub> Receptor Antagonists
Zhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Pharmaceutical Sciences
|
June 5, 2007
Near infrared spectroscopy of magnesium stearate hydrates and multivariate calibration of pseudopolymorph composition
John F Kauffman, Venkat Tumuluri, Changning Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 6, 2005
IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients
Jeffrey H Stack, Kevin Beaumont, Paul D Larsen, et al.
Epilepsia
|
August 5, 2006
Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy
Teresa Ravizza, Sian-Marie Lucas, Silvia Balosso, et al.
Antiviral Therapy
|
December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients
Keyur Patel, Seng G Lim, Chow W Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 10, 2007
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18
Woods Wannamaker, Robert Davies, Mark Namchuk, et al.
Plos Computational Biology
|
April 27, 2010
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants
Bambang S Adiwijaya, Eva Herrmann, Brian Hare, et al.
ACS Pharmacology & Translational Science
|
October 18, 2024
Chimeras Derived from a P2Y<sub>14</sub> Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation
Zhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Journal of Medicinal Chemistry
|
March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres
Young-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
Journal of Medicinal Chemistry
|
February 3, 2022
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y<sub>14</sub>R Antagonist
Zhiwei Wen, Veronica Salmaso, Young-Hwan Jung, et al.
Journal of Medicinal Chemistry
|
June 29, 2023
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y<sub>14</sub> Receptor Antagonists
Zhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Page
of 2